2013-02-05 10:18:33 - Significant financial backing by government and an upsurge in demand for regenerative medicine is bound to boost the Chinese market.
As per a new research report by RNCOS, “Global Regenerative Medicine Market”, China is becoming an important player in the regenerative medicine market landscape, including stem cell research, and tissue engineering. China has been investing heavily into application-orientated research and clinical trials in this field, and has several companies and hospitals offering therapeutic services.
China’s gross domestic expenditure on R&D activities in science and technology has grown tremendously in recent years and stem cell research, tissue engineering, and gene therapy are the key areas receiving priority funding. This funding is largely concentrated in universities, hospitals, and research institutes of China's main urban centers, especially Beijing and Shanghai.
Backed by factors, such as huge R&D investment and increasing aging population worldwide, the global
regenerative medicine market reached the mark of US$ 7.2 Billion in 2010. In future, the market will be characterized by the presence of innovative products and rising level of awareness. Overall, significant developments will create a strong demand for stem cell-based therapies and tissue-engineered products in the regenerative process.
The report identifies and analyzes key developments, including important drivers and challenges confronted by the regenerative medicine market. It not only covers possible growth areas in terms of future outlook for major industry segments and therapies in the R&D pipeline, but also provides an insight into stem cell therapy and tissue engineering sectors. The study, an outcome of an extensive research and in-depth analysis of the global regenerative medicine market, discusses forecast in key areas, and describes briefly the developments associated with active market players so that clients could get a clear picture of the regenerative medicine sector.
For FREE SAMPLE of this report visit: www.rncos.com/Report/IM363.htm
Some of our Related Reports are:
- Emerging Pharmaceutical Markets Globally ( www.rncos.com/Report/IM081.htm
- Booming Clinical Trials Market in India ( www.rncos.com/Report/IM564.htm
- Global Obesity Drug Market Analysis ( www.rncos.com/Report/IM335.htm
- Global Telemedicine Market Analysis ( www.rncos.com/Report/IM331.htm
- Clinical Trials Market in Russia ( www.rncos.com/Report/IM189.htm
Check Related REPORTS on: www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.